Results for tag: "V114"

The V114 market is a segment of the vaccine industry that focuses on the development and production of vaccines for infectious diseases. Vaccines are a form of preventive medicine that help protect individuals from contracting a disease by introducing a weakened or inactive form of the virus into the body. V114 vaccines are designed to protect against a wide range of infectious diseases, including influenza, measles, mumps, rubella, and hepatitis B. V114 vaccines are typically administered to children and adults in the form of injections, nasal sprays, or oral drops. Vaccines are typically administered in a series of doses, with the first dose providing the most protection and subsequent doses providing additional protection. Vaccines are also used to protect against emerging infectious diseases, such as Zika virus and West Nile virus. The V114 market is highly competitive, with a number of companies involved in the development and production of vaccines. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more